Not Tagged
Not Tagged
['ovarian', 'brca']
myriad recently conducted a study that describes the prevalence of pathogenic brca1/brca2 lrs in ovarian tumors and discusses the importance of their identification using a comprehensive testing strategy. learn more: #asco23 #oncology #medtwitter 
Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all.